PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WST vs. XRAY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


WSTXRAY
YTD Return-6.90%-21.95%
1Y Return-4.46%-23.97%
3Y Return (Ann)-1.75%-24.61%
5Y Return (Ann)23.49%-11.41%
10Y Return (Ann)23.41%-4.41%
Sharpe Ratio-0.12-0.92
Daily Std Dev30.08%25.95%
Max Drawdown-55.52%-60.57%
Current Drawdown-30.12%-58.38%

Fundamentals


WSTXRAY
Market Cap$24.28B$5.70B
EPS$7.60-$0.44
PEG Ratio6.721.53
Revenue (TTM)$2.93B$3.94B
Gross Profit (TTM)$1.14B$2.13B
EBITDA (TTM)$809.60M$627.00M

Correlation

-0.50.00.51.00.3

The correlation between WST and XRAY is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

WST vs. XRAY - Performance Comparison

In the year-to-date period, WST achieves a -6.90% return, which is significantly higher than XRAY's -21.95% return. Over the past 10 years, WST has outperformed XRAY with an annualized return of 23.41%, while XRAY has yielded a comparatively lower -4.41% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


4,000.00%6,000.00%8,000.00%10,000.00%12,000.00%14,000.00%December2024FebruaryMarchAprilMay
10,784.83%
4,805.06%
WST
XRAY

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


West Pharmaceutical Services, Inc.

DENTSPLY SIRONA Inc.

Risk-Adjusted Performance

WST vs. XRAY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and DENTSPLY SIRONA Inc. (XRAY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WST
Sharpe ratio
The chart of Sharpe ratio for WST, currently valued at -0.12, compared to the broader market-2.00-1.000.001.002.003.004.00-0.12
Sortino ratio
The chart of Sortino ratio for WST, currently valued at 0.04, compared to the broader market-4.00-2.000.002.004.006.000.04
Omega ratio
The chart of Omega ratio for WST, currently valued at 1.01, compared to the broader market0.501.001.502.001.01
Calmar ratio
The chart of Calmar ratio for WST, currently valued at -0.11, compared to the broader market0.002.004.006.00-0.11
Martin ratio
The chart of Martin ratio for WST, currently valued at -0.33, compared to the broader market-10.000.0010.0020.0030.00-0.33
XRAY
Sharpe ratio
The chart of Sharpe ratio for XRAY, currently valued at -0.92, compared to the broader market-2.00-1.000.001.002.003.004.00-0.92
Sortino ratio
The chart of Sortino ratio for XRAY, currently valued at -1.22, compared to the broader market-4.00-2.000.002.004.006.00-1.22
Omega ratio
The chart of Omega ratio for XRAY, currently valued at 0.86, compared to the broader market0.501.001.502.000.86
Calmar ratio
The chart of Calmar ratio for XRAY, currently valued at -0.40, compared to the broader market0.002.004.006.00-0.40
Martin ratio
The chart of Martin ratio for XRAY, currently valued at -1.26, compared to the broader market-10.000.0010.0020.0030.00-1.26

WST vs. XRAY - Sharpe Ratio Comparison

The current WST Sharpe Ratio is -0.12, which is higher than the XRAY Sharpe Ratio of -0.92. The chart below compares the 12-month rolling Sharpe Ratio of WST and XRAY.


Rolling 12-month Sharpe Ratio-1.000.001.002.00December2024FebruaryMarchAprilMay
-0.12
-0.92
WST
XRAY

Dividends

WST vs. XRAY - Dividend Comparison

WST's dividend yield for the trailing twelve months is around 0.24%, less than XRAY's 2.10% yield.


TTM20232022202120202019201820172016201520142013
WST
West Pharmaceutical Services, Inc.
0.24%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%0.78%
XRAY
DENTSPLY SIRONA Inc.
2.10%1.57%1.57%0.77%0.76%0.66%0.94%0.53%0.54%0.48%0.50%0.52%

Drawdowns

WST vs. XRAY - Drawdown Comparison

The maximum WST drawdown since its inception was -55.52%, smaller than the maximum XRAY drawdown of -60.57%. Use the drawdown chart below to compare losses from any high point for WST and XRAY. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%December2024FebruaryMarchAprilMay
-30.12%
-58.38%
WST
XRAY

Volatility

WST vs. XRAY - Volatility Comparison

The current volatility for West Pharmaceutical Services, Inc. (WST) is 5.92%, while DENTSPLY SIRONA Inc. (XRAY) has a volatility of 7.30%. This indicates that WST experiences smaller price fluctuations and is considered to be less risky than XRAY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2024FebruaryMarchAprilMay
5.92%
7.30%
WST
XRAY

Financials

WST vs. XRAY - Financials Comparison

This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and DENTSPLY SIRONA Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items